| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.1 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.31 | 0.1 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |